Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Scientific misconduct stories

Jun 29, 2026

New England Journal of Medicine Retracts Amgen's Tavneos Clinical Trial Amid Data Manipulation Allegations

The New England Journal of Medicine retracted the main clinical trial used to approve Amgen's $500 million drug Tavneos, following allegations of data manipulation. The European Medicines Agency had previously recommended revoking the drug's approval over data integrity concerns.

Jun 29, 2026·1 source
00

Top claims

  • ▪Two of the Tavneos clinical trial study's authors requested the retraction from the New England Journal of Medicine
  • ▪The retracted Tavneos clinical trial was the main study used to approve the drug
  • ▪The US Food and Drug Administration investigation found that results of nine patients in the Tavneos trial were changed after the study's database was finalized

Subtopics

Clinical evaluation1Clinical Trial Design & Evaluation1Drug Approval and Clinical Trials1Drug approval process1Drug Policy, Pricing & Approval1Drug safety1

Related timelines

Iran War

209 stories

Strait of Hormuz blockage

148 stories

Trump administration

161 stories

Congress

110 stories

Crypto hacks

100 stories